Cargando…
Therapy for metastatic melanoma: the past, present, and future
Metastatic melanoma is the most aggressive form of skin cancer with a median overall survival of less than one year. Advancements in our understanding of how melanoma evades the immune system as well as the recognition that melanoma is a molecularly heterogeneous disease have led to major improvemen...
Autores principales: | Finn, Laura, Markovic, Svetomir N, Joseph, Richard W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308914/ https://www.ncbi.nlm.nih.gov/pubmed/22385436 http://dx.doi.org/10.1186/1741-7015-10-23 |
Ejemplares similares
-
Treatment of Advanced Melanoma: Past, Present and Future
por: Fujimura, Taku, et al.
Publicado: (2020) -
HAE therapies: past present and future
por: Zuraw, Bruce L
Publicado: (2010) -
The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
por: Mansfield, Aaron S., et al.
Publicado: (2013) -
The Role of BRAF in Metastatic Colorectal Carcinoma–Past, Present, and Future
por: Djanani, Angela, et al.
Publicado: (2020) -
Adjuvant Therapy for Melanoma: Past, Current, and Future Developments
por: Testori, Alessandro A. E., et al.
Publicado: (2020)